Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SARS-CoV-2 vaccine (Beijing 302 Hospital)
- Development stage
- Unknown
- Lead developer
- The Fifth Medical Center of the PLA General Hospital
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
SARS-CoV-2 vaccine (Beijing 302 Hospital) refers to a vaccine candidate or vaccination regimen developed and clinically evaluated by the Beijing 302 Hospital (also known as the Fifth Medical Center of the PLA General Hospital). The vaccine is primarily associated with clinical research into heterologous prime-boost strategies for COVID-19. Specifically, it has been studied in Phase 1/2 trials to assess safety and immunogenicity in high-risk populations, such as patients with various stable cancers who have previously received a primary vaccination series. The vaccine aims to elicit a robust immune response against the SARS-CoV-2 virus to prevent infection and reduce disease severity, particularly in individuals who may have a diminished response to standard vaccination protocols.
- Other names
- Beijing 302 Hospital COVID-19 vaccineBeijing302 Hospital COVID-19 vaccineBeijing-302 Hospital COVID-19 vaccineFifth Medical Center of the PLA General Hospital COVID-19 vaccineCoronavirus vaccination
02
Targets
SARS-CoV-2 spike
Beyond the preview
Go deeper on SARS-CoV-2 vaccine (Beijing 302 Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SARS-CoV-2 vaccine (Beijing 302 Hospital).